# DeveloGen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/develogen

- Industry: Pharmaceuticals
- Headquarters: Gottingen, Germany
- Total disclosed funding: $38M
- Latest round: Series B (Apr 18, 2001)
- Investors on record: 10

## About

Founded in 1997 and based in Goettingen, Germany, DeveloGen AG is a biopharmaceutical company that researches and develops novel therapeutics for the treatment of metabolic and endocrine diseases, focusing on diabetes.

## Funding rounds

- Series B, Apr 18, 2001, $35M — OMTI, Global Life Science Ventures, TVM Capital Life Science, DKA Capital, Deutsche Venture Capital, Industrie Management Holding, Commerz Beteiligungsgesellschaft, Technologie-Beteiligungs-Gesellschaft
- Series A, Jan 19, 1998, $3M — Atlas Venture, Global Life Science Ventures, IMH Venture

## Investors

- Atlas Venture (https://capitalatlas.ai/funds/atlas-venture) — Series A
- Global Life Science Ventures (https://capitalatlas.ai/funds/global-life-science-ventures) — Series A, Series B
- IMH Venture — Series A
- OMTI — Series B
- TVM Capital Life Science (https://capitalatlas.ai/funds/tvm-capital-life-science) — Series B
- DKA Capital (https://capitalatlas.ai/funds/dka-capital) — Series B
- Deutsche Venture Capital (https://capitalatlas.ai/funds/deutsche-venture-capital) — Series B
- Industrie Management Holding (https://capitalatlas.ai/funds/industrie-management-holding) — Series B
- Commerz Beteiligungsgesellschaft — Series B
- Technologie-Beteiligungs-Gesellschaft — Series B